Combination treating prostate cancer, pharmaceutical composition and treatment method
AssigneeKangpu Biopharmaceuticals, Ltd.
InventorsChuansheng GE, Baisong LIAO, Wen-Cherng LEE
Life of this patent
Estimating the term…
Abstract
Disclosed are a combination treating prostate cancer, a pharmaceutical composition and a treatment method. The combination includes one of a benzoheterocyclic compound as shown in formula (I), a pharmaceutically acceptable salt thereof, a solvate thereof, a crystalline form thereof, a co-crystal thereof, a stereoisomer thereof, an isotope compound thereof, a metabolite thereof and a prodrug thereof, and an androgen receptor pathway modulator. The combination, the pharmaceutical composition thereof and the treatment method inhibit prostate cancer in a more effective manner.
Claims13
A combination for the treatment of prostate cancer, comprising active therapeutic components consisting of (i) one of a benzoheterocyclic compound, a pharmaceutically acceptable salt, a stereoisomer, an isotope compound thereof, and (ii) an androgen receptor pathway modulator;
- wherein the androgen receptor pathway modulator is selected from:
- and
- the benzoheterocyclic compound is selected from:
Dependencies are inferred from the claim text.